None
EN
Sonoma Pharmaceuticals (NASDAQ:SNOA) Issues Earnings Results, Beats Expectations By $0.21 EPS
['Stacy Sanders']
Daily Political
Sonoma Pharmaceuticals (NASDAQ:SNOA – Get Free Report) announced its quarterly earnings data on Thursday.
Sonoma Pharmaceuticals had a negative net margin of 16.26% and a negative return on equity of 43.95%.
Sonoma Pharmaceuticals Stock Up 10.6%SNOA traded up $0.12 on Thursday, reaching $1.25.
Sonoma Pharmaceuticals has a one year low of $0.85 and a one year high of $6.92.
Get Sonoma Pharmaceuticals alerts:Hedge Funds Weigh In On Sonoma PharmaceuticalsA hedge fund recently raised its stake in Sonoma Pharmaceuticals stock.